市場調查報告書
商品編碼
1331405
切向流過濾市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測,按產品、膜材料、技術、按應用、最終用戶、地區和競爭細分Tangential Flow Filtration Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Membrane Material, By Technique, By Application, By End User, By Region and By Competition |
預計全球切向流過濾市場在預測期內將出現令人印象深刻的成長。這可以歸因於切向流過濾相對於正常流過濾的優勢不斷增強,以及拋棄式技術的日益採用以及製藥和生物技術公司不斷成長的研發。此外,TFF 技術在不同下游工藝中的使用不斷增加預計將在預測期內推動市場的成長。此外,切向流過濾(TFF)在生物技術研究中用作高性能和可重複操作的優勢以及各大公司對新型 TFF 產品開發的投資不斷增加,正在推動預測期內市場的成長。 2021 年 9 月,為生物製藥製造提供拋棄式整合解決方案和服務的主導企業 ABEC 宣布推出名為客製化單運行 (CSR) 切向流過濾 (TFF) 系統的新型 TFF 系統,以大幅擴展為其生物程序客戶提供下游生產力。 ABEC 設備解決方案副總裁 Brady Cole 在一份聲明中提到,傳統的拋棄式 TFF 系統的流速要低得多,以避免爆裂。但他們的 CSR TFF 的流速超過每分鐘 240 升,可以縮短達到高產品濃度的處理時間。
生物製藥和生物製劑對全球切向流過濾(TFF)市場的成長產生重大影響。生物製藥和生物製劑需要高效、可靠的純化工藝,以確保它們對患者安全有效。 TFF 是生物製藥和生物製品純化最常用的方法之一,這推動了對 TFF 系統的需求。生物製藥和生物製劑的複雜性推動了 TFF 技術的創新,從而導致新的和改進的 TFF 系統的開發。這些系統旨在提高 TFF 工藝的效率、可擴展性和可靠性,這對於生物製藥和生物製劑的生產至關重要。在慢性病患病率上升和人口老齡化的推動下,生物製藥行業正在快速成長。這種成長推動了對 TFF 系統的需求,因為生物製藥製造商需要高效且經濟高效的純化工藝。新生物製藥和生物製劑的開發需要廣泛的研究和開發,這推動了對 TFF 系統的需求。 TFF 對於小分子的純化至關重要,使其成為生物製藥研究和開發的重要技術。過去幾年,多種 COVID-19 疫苗的開發和批准一直是生物製品行業的主要焦點。多種疫苗已使用不同平台(包括 mRNA 和病毒載體技術)開發出來,並已在許多國家獲得緊急使用授權。過去幾年已經批准了幾種新的基因療法,包括用於治療脊髓性肌萎縮症的基因療法 Zolgensma 和用於治療遺傳性視網膜營養不良的基因療法 Luxturna。基因療法使用經過修飾的病毒將缺陷基因的功能副本傳遞給患有遺傳病的患者。 CAR-T 細胞療法是一種免疫療法,涉及修改患者自身的 T 細胞以瞄準並摧毀癌細胞。近年來,多種 CAR-T 細胞療法已獲得批准,包括 Kymriah 和 Yescarta,用於治療某些類型的白血病和淋巴瘤。
生物製藥和生物製劑的複雜性推動了 TFF 技術的創新,從而導致新的和改進的 TFF 系統的開發。這些系統旨在提高 TFF 工藝的效率、可擴展性和可靠性,這對於生物製藥和生物製劑的生產至關重要。 TFF 技術的創新是開發能夠提高 TFF 系統效率和性能的新材料和膜。例如,使用具有改進的抗污染性和選擇性的高性能聚合物膜可以帶來更高的通量和更有效的目標分子分離。這些創新可以使 TFF 技術對生物製藥公司和其他需要高純度分離的行業更具吸引力。 TFF 技術的創新是開發更加自動化、高效且更具成本效益的新型 TFF 系統。例如,使用微流體裝置、自動化控制系統和整合感測器可以提高 TFF 分離的精度和重現性,同時還可以減少執行這些分離所需的時間和成本。這些創新可以使 TFF 技術更容易為更廣泛的用戶所使用,從小型生物技術初創公司到大型製藥公司。
研究活動在全球切向流過濾 (TFF) 市場的成長中發揮著重要作用。研究活動對於確定 TFF 新應用至關重要。隨著研究人員更好地了解 TFF 的功能和局限性,他們可以為該技術開發新的創新應用,從而帶來新的市場機會。研究活動可以通過確定特定應用的最佳膜材料、幾何形狀和操作條件來幫助最佳化 TFF 工藝。這使得 TFF 流程更加高效、有效,從而降低成本並提高性能。研究活動推動了 TFF 技術的創新,從而開發了新的和改進的 TFF 系統。這些系統的設計更加高效、可擴展且可靠,從而提高了 TFF 在生物製藥行業的採用和使用。研究活動可以幫助研究人員更好地了解 TFF 背後的機制,從而改進過程控制和最佳化。這使得 TFF 流程更加高效、有效,從而降低成本並提高性能。研究活動通常涉及學術機構、行業和政府之間的合作和知識共享。這種合作可以促進新的 TFF 應用和技術的開發,並加深對 TFF 機制的理解。
政府的支持可以在全球切向流過濾(TFF)市場的成長中發揮重要作用。政府可以為TFF技術的研發提供資金。這可以促進新的和改進的 TFF 系統和應用的開發,推動市場的創新和成長。政府可以為 TFF 系統和應用制定法規和指南,確保 TFF 流程的安全性和有效性。清晰一致的法規還可以減少新參與者進入市場的壁壘。政府可以為 TFF 技術的商業化提供支持,例如為投資 TFF 研發的公司提供稅收優惠或補助。這可以激勵公司投資 TFF 技術,從而增加生物製藥行業對該技術的採用和使用。政府可以投資基礎設施來支持 TFF 市場的成長,例如為 TFF 製造設施的建設或現有設施的升級提供資金。這可以提高 TFF 生產能力,降低成本並提高效率。各國政府可以談判國際貿易協定,以減少 TFF 技術和產品的進出口壁壘。這可以擴大 TFF 公司的市場覆蓋範圍,從而在全球範圍內增加該技術的採用和使用。
根據給定的市場數據,TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項:
The Global Tangential Flow Filtration Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising advantages of tangential flow filtration over normal flow filtration, along with the increasing adoption of single-use technologies and growing research and development in pharma and biotech companies. Also, the growing usage of the TFF technology in different downstream processes is expected to drive the growth of the market during the forecast period. Additionally, the advantages of tangential flow filtration (TFF) for using as a high-performance and reproducible operation in biotechnology research and increasing investments for the development of novel TFF products by major companies are driving the growth of the market during the forecast period. In September 2021, ABEC, a dominant player that delivers single-use integrated solutions & services for biopharmaceutical manufacturing, announced the launch of their new TFF system called Custom Single Run (CSR) Tangential Flow Filtration (TFF) system, in order to appreciably expand downstream productivity for their bioprocess customers. Brady Cole, the VP of Equipment Solutions at ABEC, mentioned in a statement that traditional single-use TFF systems are cramped to a much lower flow rate so as to avoid bursting. But their CSR TFF having flow rates of more than 240 liters per minute makes process times shorter to attain high product concentrations.
Biopharmaceuticals and biologics have a significant impact on the growth of the global tangential flow filtration (TFF) market. Biopharmaceuticals and biologics require highly efficient and reliable purification processes to ensure that they are safe and effective for patients. TFF is one of the most commonly used methods for the purification of biopharmaceuticals and biologics, which is driving the demand for TFF systems. The complexity of biopharmaceuticals and biologics has driven innovation in TFF technology, leading to the development of new and improved TFF systems. These systems are designed to improve the efficiency, scalability, and reliability of the TFF process, which is essential for the production of biopharmaceuticals and biologics. The biopharmaceutical industry is growing rapidly, driven by the increasing prevalence of chronic diseases and the aging population. This growth is driving the demand for TFF systems as biopharmaceutical manufacturers require efficient and cost-effective purification processes. The development of new biopharmaceuticals and biologics requires extensive research and development, which drives the demand for TFF systems. TFF is essential for the purification of small molecules, making it an essential technology for biopharmaceutical research and development. The development and approval of several COVID-19 vaccines have been a major focus in the biologics industry in the past few years. Multiple vaccines have been developed using different platforms, including mRNA and viral vector technologies, and have been authorized for emergency use in many countries. There have been several new gene therapies approved in the past few years, including Zolgensma, a gene therapy for spinal muscular atrophy, and Luxturna, a gene therapy for inherited retinal dystrophy. Gene therapies use modified viruses to deliver a functional copy of a defective gene to patients with genetic diseases. CAR-T cell therapies are a type of immunotherapy that involves modifying a patient's own T-cells to target and destroy cancer cells. Several CAR-T cell therapies have been approved in recent years, including Kymriah and Yescarta, which are used to treat certain types of leukemia and lymphoma.
The complexity of biopharmaceuticals and biologics has driven innovation in TFF technology, leading to the development of new and improved TFF systems. These systems are designed to improve the efficiency, scalability, and reliability of the TFF process, which is essential for the production of biopharmaceuticals and biologics. Innovation in TFF technology is the development of new materials and membranes that can improve the efficiency and performance of TFF systems. For example, the use of high-performance polymeric membranes with improved fouling resistance and selectivity can lead to higher throughput and more efficient separation of target molecules. These innovations can make TFF technology more attractive to biopharmaceutical companies and other industries that require high-purity separations. Innovation in TFF technology is the development of new TFF systems that are more automated, efficient, and cost-effective. For example, the use of microfluidic devices, automated control systems, and integrated sensors can improve the precision and reproducibility of TFF separations while also reducing the time and cost required to perform these separations. These innovations can make TFF technology more accessible to a wider range of users, from small biotech startups to large pharmaceutical companies.
Research activities play a significant role in the growth of the global tangential flow filtration (TFF) market. Research activities are essential for identifying new applications for TFF. As researchers better understand the capabilities and limitations of TFF, they can develop new and innovative applications for the technology, leading to new market opportunities. Research activities can help optimize TFF processes by identifying the best membrane materials, geometries, and operating conditions for specific applications. This leads to more efficient and effective TFF processes, reducing costs and improving performance. Research activities drive innovation in TFF technology, leading to the development of new and improved TFF systems. These systems are designed to be more efficient, scalable, and reliable, leading to increased adoption and use of TFF in the biopharmaceutical industry. Research activities can help researchers better understand the mechanisms behind TFF, leading to improved process control and optimization. This leads to more efficient and effective TFF processes, reducing costs and improving performance. Research activities often involve collaboration and knowledge sharing between academic institutions, industry, and government. This collaboration can lead to the development of new TFF applications and technologies, as well as an improved understanding of TFF mechanisms.
Government support can play a significant role in the growth of the global tangential flow filtration (TFF) market. Governments can provide funding for the research and development of TFF technology. This can lead to the development of new and improved TFF systems and applications, driving innovation and growth in the market. Governments can establish regulations and guidelines for TFF systems and applications, ensuring the safety and efficacy of TFF processes. Clear and consistent regulations can also reduce barriers to entry for new players in the market. Governments can provide support for the commercialization of TFF technology, such as tax incentives or grants for companies that invest in TFF research and development. This can incentivize companies to invest in TFF technology, leading to increased adoption and use of the technology in the biopharmaceutical industry. Governments can invest in infrastructure to support the growth of the TFF market, such as funding for the construction of TFF manufacturing facilities or upgrades to existing facilities. This can increase the capacity for TFF production, reducing costs and increasing efficiency. Governments can negotiate international trade agreements that reduce barriers to the export and import of TFF technology and products. This can increase the market reach of TFF companies, leading to increased adoption and use of the technology globally.
Global Tangential Flow Filtration market can be segmented by product, membrane material, technique, application, end-user, region, and competitive landscape. Based on the product, the market can be segmented into Single Use Systems, Reusable Systems, Membrane Filters, and Filtration Accessories. Based on membrane material, the market can be segmented into PES, Polyvinylidene Difluoride, Nylon, PTFE, Mixed cellulose ester & cellulose acetate, PCTE, Regenerated Cellulose, and Other membrane materials. Based on the technique, the market can be differentiated into Microfiltration, Ultrafiltration, Nanofiltration, and Other Techniques. Based on application, the market can be segmented into Final product processing, Raw material filtration, Cell separation, Water purification, and Air purification. Based on the end user, the market can be differentiated into Pharmaceutical & Biotechnology companies, Contract research organizations, and Academic & Research institutes. Regionally, North America dominates the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominates the Global Tangential Flow Filtration Market on account of the growing well-developed laboratories in the country.
Merck KGAA., Danaher Corporation, Sartorius AG, Parker Hannifin Corporation, Repligen Corporation, Alfa Laval Corporate AB., Andritz, Meissner Filtration Products Inc., Cole Parmer Instrument Company Inc., and Sterlitech Corporation are some of the leading players operating in the Global Tangential Flow Filtration Market.
In this report, Global Tangential Flow Filtration Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Tangential Flow Filtration Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: